What is Day One Biopharmaceuticals (DAWN)?
Day One Biopharmaceuticals is a biotechnology company focused on the development of therapies for the treatment of cancer and other serious diseases. The company engages in research and development activities aimed at discovering and advancing novel drug candidates. Its pipeline includes targeted therapies designed to address specific molecular pathways involved in disease progression. Day One Biopharmaceuticals collaborates with academic institutions and industry partners to support its scientific initiatives. The company operates within the biopharmaceutical sector, emphasizing innovation in drug development to address unmet medical needs.
Day One Biopharmaceuticals Stock Price Today: Live Overview
The price today is shaped by trading fluctuations, with Day One Biopharmaceuticals at $21.47. It has traded within the range of $21.31 to $21.34, reflecting a daily percentage change of +0.0939%.
FAQ: Day One Biopharmaceuticals (DAWN)
What is the current price of DAWN stock?
Day One Biopharmaceuticals is currently priced at $21.47.
Does DAWN pay dividends?
Day One Biopharmaceuticals does not pay dividends.
Does DAWN have a formal corporate presence or regional headquarters in the UAE?
Day One Biopharmaceuticals has no official regional office or subsidiary in the UAE and operates without a registered presence there.
What is DAWN best known for?
Day One Biopharmaceuticals is most famous for developing innovative cancer therapies.
What assets are typically shown together with DAWN?
Commonly shown alongside DAWN: Digital Turbine Inc., KGHM Polska Miedz SA, Union Pacific
Latest shares articles



